MetRS Antibodies

Santa Cruz Biotechnology features a diverse variety of MetRS Antibodies, specifically targeting Methionyl-tRNA synthetase (MetRS). MetRS Antibodies are available for various research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Methionyl-tRNA synthetase plays a crucial role in protein synthesis by catalyzing the attachment of methionine to its corresponding tRNA, a vital step in the initiation of translation. The enzyme is essential for cellular function and growth, and dysregulation has been implicated in various diseases, including cancer and neurodegenerative disorders. Understanding the role of Methionyl-tRNA synthetase can provide significant insights into pathological conditions. Research utilizing MetRS monoclonal antibodies has revealed important mechanisms in cellular protein synthesis and regulation. Investigating MetRS function has led to discoveries in disease progression and potential therapeutic targets. MetRS research continues to uncover new aspects of translation initiation and cellular homeostasis. Santa Cruz Biotechnology monoclonal antibodies for MetRS support researchers worldwide in advancing scientific understanding of protein synthesis and disease mechanisms.